Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2011

01-01-2011 | Review

Segmental Colitis Associated with Diverticulosis: Complication of Diverticular Disease or Autonomous Entity?

Author: Antonio Tursi

Published in: Digestive Diseases and Sciences | Issue 1/2011

Login to get access

Abstract

Segmental colitis associated with diverticulosis (SCAD) is a disease that affects colon harboring diverticula, mostly located in the sigmoid region. It has been considered a rare disease for many years, but new studies may contribute to easier recognition. Although its pathogenesis is not yet well defined, in the past SCAD has been considered a complication of diverticular disease, whilst new endoscopic, histological, and clinical data have encouraged the concept that SCAD includes pathogenetic and therapeutic aspects peculiar to inflammatory bowel diseases. We therefore describe herein current knowledge about this disease, and why it can be considered a truly autonomous entity instead of a complication of diverticular disease.
Literature
1.
go back to reference Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1974;4:53–69. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1974;4:53–69.
2.
go back to reference Hughes LE. Post-mortem survey of diverticular disease of the colon I. Diverticulosis and diverticulitis. Gut. 1969;10:336–344.CrossRefPubMed Hughes LE. Post-mortem survey of diverticular disease of the colon I. Diverticulosis and diverticulitis. Gut. 1969;10:336–344.CrossRefPubMed
3.
go back to reference Tursi A. New physiopathological and therapeutic approaches to diverticular disease disease of the colon. Expert Opin Pharmacoter. 2007;8:299–307.CrossRef Tursi A. New physiopathological and therapeutic approaches to diverticular disease disease of the colon. Expert Opin Pharmacoter. 2007;8:299–307.CrossRef
4.
go back to reference Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Lecca PG, Di Cesare L, Inchingolo CD, Aiello F (2009) The endoscopic spectrum of segmental colitis associated with diverticulosis. Colorectal Dis [Epub ahead of print] PMID: 19558591 (in press). Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Lecca PG, Di Cesare L, Inchingolo CD, Aiello F (2009) The endoscopic spectrum of segmental colitis associated with diverticulosis. Colorectal Dis [Epub ahead of print] PMID: 19558591 (in press).
5.
go back to reference Harpaz N, Sachar DB. Segmental colitis associated with diverticular disease and other IBD look-alikes. J Clin Gastroenterol. 2006;40:S132–S135.CrossRefPubMed Harpaz N, Sachar DB. Segmental colitis associated with diverticular disease and other IBD look-alikes. J Clin Gastroenterol. 2006;40:S132–S135.CrossRefPubMed
6.
go back to reference Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol. 2007;5:27–31.CrossRefPubMed Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol. 2007;5:27–31.CrossRefPubMed
7.
go back to reference Imperiali G, Meucci G, Alvisi C, et al. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol. 2000;95:1014–1016.CrossRefPubMed Imperiali G, Meucci G, Alvisi C, et al. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol. 2000;95:1014–1016.CrossRefPubMed
8.
go back to reference Koutroubakis IE, Antoniou P, Tzardi M, Kouroumalis EA. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis. 2005;20:28–32.CrossRefPubMed Koutroubakis IE, Antoniou P, Tzardi M, Kouroumalis EA. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis. 2005;20:28–32.CrossRefPubMed
9.
go back to reference Ierardi E, Meucci G, Hassan C, et al. Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci. 2008;53:1865–1868.CrossRefPubMed Ierardi E, Meucci G, Hassan C, et al. Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci. 2008;53:1865–1868.CrossRefPubMed
10.
go back to reference Goldstein NS, Leon-Armin C, Mani A. Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn’s disease. Am J Surg Pathol. 2000;24:668–675.CrossRefPubMed Goldstein NS, Leon-Armin C, Mani A. Crohn’s colitis-like changes in sigmoid diverticulitis specimens is usually an idiosyncratic inflammatory response to the diverticulosis rather than Crohn’s disease. Am J Surg Pathol. 2000;24:668–675.CrossRefPubMed
11.
go back to reference Tursi A, Inchingolo CD, Nenna R, et al. Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity. Inflamm Bowel Dis. 2008;14:1315–1317.CrossRefPubMed Tursi A, Inchingolo CD, Nenna R, et al. Pattern of mucosal tumor necrosis factor-alpha expression in segmental colitis associated with diverticula suggests a truly autonomous clinical entity. Inflamm Bowel Dis. 2008;14:1315–1317.CrossRefPubMed
12.
go back to reference Rutgeerts P, Van Assche G, Vermeire S. Review article: infliximab therapy for inflammatory bowel disease–seven years on. Aliment Pharmacol Ther. 2006;23:451–463.CrossRefPubMed Rutgeerts P, Van Assche G, Vermeire S. Review article: infliximab therapy for inflammatory bowel disease–seven years on. Aliment Pharmacol Ther. 2006;23:451–463.CrossRefPubMed
13.
go back to reference Hassan C, Zullo A, Ierardi E, Burattini O, De Francesco V, Morini S. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut. 2006;55:589–590.CrossRefPubMed Hassan C, Zullo A, Ierardi E, Burattini O, De Francesco V, Morini S. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut. 2006;55:589–590.CrossRefPubMed
14.
go back to reference Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699–703.CrossRefPubMed Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol. 2008;42:699–703.CrossRefPubMed
15.
go back to reference Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol. 1996;20:94–102.CrossRefPubMed Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol. 1996;20:94–102.CrossRefPubMed
16.
go back to reference Evans JPI, Cooper J, Roediger WEW. Diverticular colitis–therapeutic and aetiological considerations. Colorectal Dis. 2002;4:208–212.CrossRefPubMed Evans JPI, Cooper J, Roediger WEW. Diverticular colitis–therapeutic and aetiological considerations. Colorectal Dis. 2002;4:208–212.CrossRefPubMed
17.
go back to reference Freeman H. Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome). Dig Dis Sci. 2008;53:2452–2457.CrossRefPubMed Freeman H. Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome). Dig Dis Sci. 2008;53:2452–2457.CrossRefPubMed
18.
go back to reference Imperiali G, Terpin MM, Meucci G, Ferrara A, Minoli G. Segmental colitis associated with diverticula: a 7-year follow-up study. Endoscopy. 2006;38:610–612.CrossRefPubMed Imperiali G, Terpin MM, Meucci G, Ferrara A, Minoli G. Segmental colitis associated with diverticula: a 7-year follow-up study. Endoscopy. 2006;38:610–612.CrossRefPubMed
19.
go back to reference Hadithi M, Cazemier M, Meijer GA, et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol. 2008;14:3183–3187.CrossRefPubMed Hadithi M, Cazemier M, Meijer GA, et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol. 2008;14:3183–3187.CrossRefPubMed
20.
go back to reference Peppercorn MA. Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol. 1992;87:609–612.PubMed Peppercorn MA. Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol. 1992;87:609–612.PubMed
21.
go back to reference Pereira MC. Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc. 1998;48:520–523.CrossRefPubMed Pereira MC. Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc. 1998;48:520–523.CrossRefPubMed
22.
go back to reference Polit SA. Chronic segmental colitis in association with diverticulosis: a clinical syndrome in elderly? J Am Geriatr Soc. 1993;41:1155–1156.PubMed Polit SA. Chronic segmental colitis in association with diverticulosis: a clinical syndrome in elderly? J Am Geriatr Soc. 1993;41:1155–1156.PubMed
23.
go back to reference Gore S, Sheperd NA, Wilkinson SP. Endoscopic crescent fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis. 1992;7:76–81.CrossRefPubMed Gore S, Sheperd NA, Wilkinson SP. Endoscopic crescent fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis. 1992;7:76–81.CrossRefPubMed
24.
go back to reference Brandimarte G, Elisei W, Giorgetti GM, Di Cesare L, Aiello F, Tursi A. Can endoscopy differentiate between ulcerative colitis with diverticulosis, segmental colitis associated with diverticulosis (“SCAD”), and acute uncomplicated colonic diverticulitis? Digest Liver Dis. 2009;41(Suppl. 1):S148.CrossRef Brandimarte G, Elisei W, Giorgetti GM, Di Cesare L, Aiello F, Tursi A. Can endoscopy differentiate between ulcerative colitis with diverticulosis, segmental colitis associated with diverticulosis (“SCAD”), and acute uncomplicated colonic diverticulitis? Digest Liver Dis. 2009;41(Suppl. 1):S148.CrossRef
25.
go back to reference Croucher LJ, Bury JP, Williams EA, Riley SA, Corfe BM. Commonly used bowel preparations have significant and different effects upon cell proliferation in the colon: a pilot study. BMC Gastroenterol. 2008;8:54.CrossRefPubMed Croucher LJ, Bury JP, Williams EA, Riley SA, Corfe BM. Commonly used bowel preparations have significant and different effects upon cell proliferation in the colon: a pilot study. BMC Gastroenterol. 2008;8:54.CrossRefPubMed
27.
go back to reference Cammarota G, Cesaro P, Cazzato A, et al. Hydrogen peroxyde-related colitis (previously known as “pseudolipomatosis”): a series of cases occurring in an epidemic pattern. Endoscopy. 2007;39:916–919.CrossRefPubMed Cammarota G, Cesaro P, Cazzato A, et al. Hydrogen peroxyde-related colitis (previously known as “pseudolipomatosis”): a series of cases occurring in an epidemic pattern. Endoscopy. 2007;39:916–919.CrossRefPubMed
28.
go back to reference Rizzello F, Gionchetti P, D’Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2002;16:1109–1116.CrossRefPubMed Rizzello F, Gionchetti P, D’Arienzo A, et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther. 2002;16:1109–1116.CrossRefPubMed
29.
go back to reference Tursi A. Balsalazide plus high-potency probiotic preparation VSL#3 in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon. J Clin Gastroenterol. 2008;42(Supplement 3, part 1):S119–S122.CrossRefPubMed Tursi A. Balsalazide plus high-potency probiotic preparation VSL#3 in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon. J Clin Gastroenterol. 2008;42(Supplement 3, part 1):S119–S122.CrossRefPubMed
30.
go back to reference Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Beclomethasone dipropionate plus VSL#3 for the treatment of mild-to-moderate diverticular colitis: an open, pilot study. J Clin Gastroenterol. 2005;39:644–646.CrossRefPubMed Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Beclomethasone dipropionate plus VSL#3 for the treatment of mild-to-moderate diverticular colitis: an open, pilot study. J Clin Gastroenterol. 2005;39:644–646.CrossRefPubMed
31.
go back to reference Mulhall AM, Mahid SS, Petras RE, Galandiuk S. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum. 2009;52:1072–1079.PubMed Mulhall AM, Mahid SS, Petras RE, Galandiuk S. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum. 2009;52:1072–1079.PubMed
32.
go back to reference Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135:781–786.CrossRefPubMed Porter CK, Tribble DR, Aliaga PA, Halvorson HA, Riddle MS. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology. 2008;135:781–786.CrossRefPubMed
Metadata
Title
Segmental Colitis Associated with Diverticulosis: Complication of Diverticular Disease or Autonomous Entity?
Author
Antonio Tursi
Publication date
01-01-2011
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2011
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1230-5

Other articles of this Issue 1/2011

Digestive Diseases and Sciences 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine